About 3,425 results

ALLMedicine™ Yellow Fever Center

Research & Reviews  1,148 results

Recombinant vesicular stomatitis vaccine against nipah virus has a favorable safety pro...
PLoS Pathogens; Monath TP, Nichols R et. al.

Jun 28th, 2022 - Nipah virus (NiV) disease is a bat-borne zoonosis responsible for outbreaks with high lethality and is a priority for vaccine development. With funding from the Coalition of Epidemic Preparedness Innovations (CEPI), we are developing a chimeric va...

A recent chikungunya outbreak associated with the occurrence of Aedes vectors (Diptera:...
Parasitology International; Siam HA, Elaagip A et. al.

Jun 26th, 2022 - Aedes aegypti and Ae. albopictus (Diptera: Culicidae) are primary vectors of human arboviral diseases such as dengue, chikungunya, yellow fever, and Zika viruses. Aedes aegypti is well distributed in Sudan, except in Northern and Khartoum states, ...

Previous biological therapy and impairment of the IFN-γ/IL-10 axis are associated with ...
Vaccine Casagrande TZ, Costa-Rocha IAD et. al.

Jun 22nd, 2022 - Yellow fever (YF) vaccination is known to induce a suboptimal response in patients with autoimmune diseases (AIDs). To date, few studies have focused on the performance of 17DD-YF vaccination in patients with spondyloarthritis (SpA). In general, p...

Animal venoms as a source of antiviral peptides active against arboviruses: a systemati...
https://doi.org/10.1007/s00705-022-05494-8 10.1016/j.onehlt.2017.06.001 10.1007/s10096-018-3375-7 10.1016/j.tmaid.2016.07.002 10.1038/nature12060 10.1002/rmv.2056 10.21577/0103-5053.20160242 10.1007/s00705-017-3641-5 10.1021/acs.jcim.9b00933 10.1021/acs.jcim.9b00809 10.3390/toxins12070451 10.1016/j.bcp.2017.03.005 10.2174/1568026616666160930151242 10.4331/wjbc.v6.i2.28 10.1007/s41048-018-0067-x 10.1590/S1678-91992009000300021 10.1016/j.toxicon.2018.07.008 10.1016/j.ejps.2020.105592 10.1038/s41429-021-00421-6 10.1002/ptr.6872 10.1007/s12275-016-6376-1 10.1007/s00726-009-0385-x 10.1177/1535370220966963 10.2174/1389203721666200116091911 10.3390/toxins11040203 10.1586/14787210.2014.976613 10.1371/journal.pmed.1000100 10.1016/j.tmaid.2019.07.015 10.2307/2529310 10.1007/s00018-008-8250-8 10.1007/s10989-019-09888-2 10.3390/toxins11100584 10.1007/s12250-018-0068-4 10.1074/jbc.RA118.005015 10.1016/j.virol.2017.11.009 10.1186/1471-2180-14-140 10.1016/j.antiviral.2014.05.019 10.1016/j.peptides.2013.07.014 10.3389/fmicb.2020.01871 10.1021/jm300655h 10.3390/biom10050790 10.1016/j.pop.2018.05.001 10.1136/bmjgh-2017-000530 10.3390/toxins2122851 10.3389/fmicb.2013.00321 10.3390/v7102883 10.5433/2316-52002014v3p2p16 10.1128/jvi.78.24.13708-13716.2004 10.1128/jvi.06225-11 10.1016/j.peptides.2013.10.021
Archives of Virology; Lima WG, Maia CQ et. al.

Jun 21st, 2022 - Arthropod-borne viruses (arboviruses), such as Zika virus (ZIKV), chikungunya virus (CHIKV), dengue virus (DENV), yellow fever virus (YFV), and West Nile virus (WNV), are pathogens of global importance. Therefore, there has been an increasing need...

Study on an Investigational Yellow Fever Vaccine Compared With Stamaril in Adults in Europe and Asia

Jun 21st, 2022 - The duration of each participant's participation will be approximately 5 years.

see more →

Drugs  3 results see all →

Clinicaltrials.gov  65 results

Study on an Investigational Yellow Fever Vaccine Compared With Stamaril in Adults in Europe and Asia

Jun 21st, 2022 - The duration of each participant's participation will be approximately 5 years.

A Phase III, Multicenter, Double Blind, Randomized Study of SII Yellow Fever Vaccine to Compare Safety and Immunogenicity With STAMARIL

Jun 16th, 2022 - There will be three scheduled visits during the study. A screening and vaccination visit (Day 0) followed by additional study visits on Day 28 and on Day 180 post-vaccination. Throughout the study, participants/parent/guardian will be encouraged t...

Trial of an Inactivated Yellow Fever Virus Vaccine

Jun 6th, 2022 - This trial will be a randomized, placebo controlled, double-blind (within dosing group), dose escalation Phase 1 trial evaluating dosages of 1 mcg and 5 mcg of HydroVax-002 YFV vaccine given intramuscularly on Day 1 (the day of first vaccination i...

Reducing Health Care Workers Absenteeism in Covid-19 Pandemic Through BCG Vaccine

Jun 3rd, 2022 - Since the beginning of 2020, SARS-CoV-2 spread rapidly throughout China and the rest of the world, with on 27 February 2020 the first detected case in the Netherlands. According to the WHO, Health-care workers (HCW) face an elevated risk of exposu...

Assessment of Safety and Immunogenicity of a Single Vial Presentation of R21/Matrix-M and Co-Administration With EPI Vaccines

May 26th, 2022 - This trial has six groups. This will be a double-blind, individually randomised trial, with 1:1 randomisation with the single or two vial presentation of R21/Matrix-M malaria vaccine for study groups 1, 2 and 3. Groups 1, 2 and 3 are to assess the...

see more →

News  147 results

WHO Set to Decide if Monkeypox Represents Health Emergency

Jun 15th, 2022 - LONDON (Reuters) - The World Health Organization will convene an emergency committee on Thursday next week to assess whether the monkeypox outbreak represents a public health emergency of international concern (PHEIC). That is the highest level of...

New Vaccine Plant in Senegal Gets 75 Million Euros From EIB

Jun 3rd, 2022 - DAKAR (Reuters) - The European Investment Bank (EIB) committed 75 million euros ($80 million) on Thursday to finance construction of a new facility in Senegal that will produce COVID-19 and other vaccines for use across Africa. The plant, run by t...

Africa Seeing Uptick in COVID Cases Driven by South Africa, WHO Says

Apr 29th, 2022 - JOHANNESBURG/NAIROBI/DAKAR (Reuters) - Africa is seeing an uptick in COVID-19 infections, largely driven by a doubling in cases reported in South Africa, the World Health Organization said on Thursday, urging people across the continent to continu...

Alert - Yellow Fever in Nigeria

There is an outbreak of yellow fever in Nigeria. Travelers to Nigeria should take steps to prevent yellow fever by getting vaccinated at least 10 days before travel and taking steps to prevent mosquito bites.

Neutralizing Antibody Response to Yellow Fever Vaccination Attenuated in South America

Jan 10th, 2022 - NEW YORK (Reuters Health) - The yellow fever virus (YFV) vaccine may not do as well at neutralizing the current Brazilian strain as it does against the virulent strain in Africa, challenging the World Health Organization's global strategy to elimi...

see more →

Patient Education  7 results see all →